Portfolio Update
Octopus AIM VCT 2 plc Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc as at 13 September 2023 is as follows : Portfolio companySectorBook cost Movement in valuation Fair...
Stay updated with breaking news from Reneuron Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Octopus AIM VCT 2 plc Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc as at 13 September 2023 is as follows : Portfolio companySectorBook cost Movement in valuation Fair...
The Stem Cell Therapies Market is anticipated to increase from US$ 187 million in 2021 to US$ 401 million by 2026, at a CAGR of 16.7%, by 2032.The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of healt...
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said it has taken an important step forward with plans to differentiate its exosome platform by generating in vivo...
UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant advancements in the field of exosome research on Monday.
ReNeuron Group PLC - Brigend, Wales-based stem cell and exosomes technology company - Generates in vivo data to exemplify cellular and tissue targeting capabilities of exosomes, produced from its...